![\"\"](\"https://inventivs.net/wp-content/uploads/2023/04/file-8731762959805314856-725x1024.png\")
\n Universal glycoforms refer to the glycan structures that are common across different species and tissues, making them ideal targets for glycoengineering. The market for compositions and methods that enable the production of universal glycoforms is driven by the growing demand for biologics, such as monoclonal antibodies, vaccines, and recombinant proteins, which require specific glycan structures for optimal efficacy and safety.
\nThe global market for glycoengineering is expected to reach USD 2.5 billion by 2025, with a compound annual growth rate (CAGR) of 10.3% from 2020 to 2025. The increasing prevalence of chronic diseases, such as cancer, autoimmune disorders, and infectious diseases, is driving the demand for biologics, which in turn is fueling the growth of the glycoengineering market.
\nThe market for compositions and methods relating to universal glycoforms is highly competitive, with several key players dominating the market. These players include GlycoFi (a subsidiary of Merck & Co.), Glycotope GmbH, ProBioGen AG, and Glycosyn LLC, among others. These companies offer a range of glycoengineering services, including glycan analysis, glycan synthesis, and glycan optimization, to meet the specific needs of their clients.
\nThe market for compositions and methods relating to universal glycoforms is also characterized by a high degree of innovation, with several companies investing heavily in research and development to develop new and improved glycoengineering technologies. For example, GlycoFi has developed a proprietary yeast-based glycoengineering platform that enables the production of complex glycan structures in a scalable and cost-effective manner. Similarly, Glycotope has developed a unique glycan synthesis technology that enables the production of fully humanized glycoproteins with optimized glycan structures.
\nIn conclusion, the market for compositions, methods, and compositions relating to universal glycoforms is a rapidly growing and highly competitive market, driven by the increasing demand for glycoengineering in various applications. With the growing prevalence of chronic diseases and the increasing demand for biologics, the market for glycoengineering is expected to continue to grow in the coming years, presenting significant opportunities for companies operating in this space.\n
\n \n
The present disclosure relates primarily to compositions or methods of use that contain antibodies, binding fragments of antibodies and universal Fc glycoforms.
\n\n ![\"\"](\"https://inventivs.net/wp-content/uploads/2023/04/file-14559898025536352462-779x1024.png\")
\n
Chemical Definitions
\nEXAMPLES
\nExample 1 : Exemplary structure of optimized universal Fc Glycan
\nExample 2″: General Example for the Preparation and Analysis of Homogeneous Immunes with the Optimized Universal glycan at Fc Region
\nExample 3 : Preparation Homogeneous Immune with Universal Glycan in the Fc Region to Enhance Monoclonal antibody Mediated Antiviral Therapeutics”.
\nExample 4
\nExample 5 – Exemplary methods and materials for ADCC assay
\nExamples: Anti-Stem monoclonal Antibodies F10 and FI6
\nExample 6
\nExample 8: Enhancement of Monoclonal antibody Mediated Anti-Cancer Therapeutics by Preparation with Homogeneous Glycan in the Fc Region
\n\n ![\"\"](\"https://inventivs.net/wp-content/uploads/2023/04/file-9783049094277003402-904x1024.png\")
\n
REPRESENTATIVE EXAMPLES
\nExample 8
\nExample 9 CDC Activities with Anti-CD20 Glycoantibodies
\nExample 10 – Binding B-Lymphoma cells
\nExample 11 : CDC to B Lymphoma Cells
\nExample 11
\nExample 12 – Binding B-Lymphoma cells
\nExample 14: Binding FcRIIIa to CHO Cells that Express the Protein
\nExample 14: Generation of Anti-SSEA-4 Monoclonal Antibodies.
\nExample 14 : Generations of chimeric antibodies
\n\n ![\"\"](\"https://inventivs.net/wp-content/uploads/2023/04/file-17710301502997157217-522x1024.png\")
\n
Example 15 : Binding analysis of antibodies to cancer cells by flow cytometry
\n\n ![\"\"](\"https://inventivs.net/wp-content/uploads/2023/04/file-169076124547750406-865x1024.png\")
\n
Click here to view the patent on Google Patents.
\n","id":"cG9zdDo4OTE2","uri":"/invention-for-compositions-methods-and-compositions-relating-to-universal-glycoforms-us20180265590a1/","title":"Invention for Compositions, methods and compositions relating to universal glycoforms","tags":{"nodes":[{"name":"Patent Review"}]},"categories":{"nodes":[{"name":"Therapeutic Antibodies"}]},"featuredImage":{"node":{"mediaItemUrl":"https://wp.inventiv.org/wp-content/uploads/2023/04/file-8731762959805314856.png"}}}},"pageContext":{"slug":"invention-for-compositions-methods-and-compositions-relating-to-universal-glycoforms-us20180265590a1","neId":"8916","categories":["3D Printing","Animal Health","Apple","Artificial Intelligence","Autonomous Vehicles","Biopharmaceuticals","Blockchain Fintech","Cannabis Patents and Trademarks","Chemical Products","Communications","Consumer Products","Digital Healthcare","Electronics","Food Science Packaging","Industrial Products","Infectious Diseases","Internet","Medical Device","Metaverse","Nanotechnology","Prescription & OTC Drugs","Software","Start Up","Therapeutic Antibodies","uncategorized"],"tags":["Alphabet","Amazon","Facebook/Meta","Microsoft","Patent Review","Samsung"],"siteUrl":"https://inventivs.net"}}, "staticQueryHashes": ["764694655"]}